Stephanie Wisner
Co-Founder, Treasurer, Chief Business Officer
Stephanie Wisner is a seasoned biotech entrepreneur and operations executive with over a decade of experience in the life sciences industry. As the Co-Founder, Treasurer, and Chief Business Officer of Centivax, she plays a pivotal role in driving the company's strategic direction, financial management, and operational efficiency.
Professional Overview
Stephanie's expertise spans business development, financial planning, and strategic operations in the biotech and pharmaceutical sectors. She is adept at navigating the complexities of early-stage startups, leveraging her strong technical background and keen business acumen to transform innovative ideas into successful commercial ventures.
Current Role
At Centivax, Stephanie is responsible for overseeing the company's business operations, including financial management, partnership development, and strategic planning. She has been instrumental in securing funding, forging strategic alliances, and optimizing the company's operational processes to accelerate the development and commercialization of its novel therapeutics.
Career Progression
Prior to co-founding Centivax, Stephanie served as an Analyst at ARCH Venture Partners, where she evaluated investment opportunities and provided strategic guidance to portfolio companies. She also held positions as the VP of Operations at Laurel Therapeutics, Inc. and a Post-Baccalaureate Research Associate at the University of Michigan Medical School, gaining valuable experience in various facets of the biotech industry.
Academic Background
Stephanie holds a Bachelor's degree in Biochemistry from Cornell University, where she also conducted research as a Research Associate. Her strong technical foundation, combined with her business acumen, has enabled her to bridge the gap between scientific innovation and commercial success.
Areas of Expertise
- Business strategy and operations management
- Financial planning and capital raising
- Biotech and pharmaceutical industry knowledge
- Startup ecosystem and venture capital
- Technical expertise in molecular biology and biochemistry
Professional Impact
As a Co-Founder of Centivax, Stephanie has played a pivotal role in establishing the company as a leading player in the development of novel immunotherapies. She has successfully negotiated partnerships, secured funding, and implemented efficient operational processes, positioning Centivax for long-term growth and success.
Conclusion
Stephanie Wisner's unique blend of technical expertise, business acumen, and entrepreneurial drive has made her a valuable asset in the biotech industry. As she continues to lead Centivax's business operations and strategic initiatives, she is poised to make significant contributions to the advancement of life-saving therapies and the overall growth of the biotech ecosystem.
